The Middle East Respiratory Syndrome Coronavirus (Mers-CoV) – What is the Risk? A Review of Recent Studies

Open access

Abstract

MERS (Middle East Respiratory Syndrome) is a viral disease of the respiratory system caused by coronaviruses (CoV), which can be contagious to both animals and humans. It was first described in 2012 in Saudi Arabia and very quickly its occurrence was found in European countries. Initially, it was associated with mild changes within the respiratory system, until a new type of virus was isolated in a patient with severe pneumonia and renal failure, who died. The study showed a close relationship between the virus isolated from the patient’s cells with HKU4 and HKU5 coronaviruses, previously isolated from bats. The presence of the same virus was found in a patient from Qatar with a similar clinical image. MERS infections, despite relatively low infectivity, are characterized by high mortality (30%). It is believed that the most likely source of the virus for humans are camels. The objective of this article is to review and discuss data on the risk factors of MERS-CoV zoonotic transmission from animals to humans.

Abbott C.A., Baker E., Sutherland G.R., Mc Caughan G.W. (1994). Genomic organization, exact localization, and tissue expression of the human CD26 (dipeptidyl peptidase IV) gene. Immunogenetics, 40: 331-338.

Adney D.R.,van Doremalen N., Brown V.R., Bushmaker T., Scott D.,de Wit E., Bowen R.A., Munster V.J. (2014). Replication and shedding of MERS-Co Vin upper respiratory tract of inoculated dromedary camels. Emerg. Infect. Dis., 20: 1999-2005.

Al-Abdallat M.M., Payne D.C., Alqasrawi S., Rha B., Tohme R.A., Abedi G.R., Al Nsour M., Iblan I., Jarour N., Farag N.H., Haddadin A., Al-Sanouri T., Tamin A., Harcourt J.L., Kuhar D.T., Swerdlow D.L., Erdman D.D., Pallansc h M.A., Haynes L.M., Gerber S.I., Jordan MERS-Co V Investigation Team. (2014). Hospitalassociated outbreak of Middle East respiratory syndrome coronavirus:aserologic, epidemiologic, and clinical description. Clin. Infect. Dis., 59: 1225-1233.

Al-Tawfiq J.A., Memish Z.A. (2014). Middle East respiratory syndrome coronavirus: epidemiology and disease control measures. Infect. Drug. Resist., 7: 281-287.

Alexandersen S., Kobinger G.P., Soule G., Wernery U. (2014). Middle East respiratory syndrome coronavirus antibody reactors among camels in Dubai, United Arab Emirates, in 2005. Transbound. Emerg. Dis., 61: 105-108.

Annan A., Baldwin H.J., Corman V.M., Klose S.M., Owusu M., Nkrumah E.E., Badu E.K., Anti P., Agbenyega O., Meyer B., Oppong S., Sarkodie Y.A., Kal- ko E.K., Lina P.H., Godlevska E.V., Reusken C., Seebens A., Gloza- Rausch F., Vallo P., Tschapka M., Drosten C., Drexler J.F. (2013). Human betacoronavirus 2c EMC/2012-related viruses in bats, Ghana and Europe. Emerg. Infect. Dis., 19: 456-459.

Arabi Y.M., Harthi A., Hussein J., Bouchama A., Johani S., Hajeer A.H., Saeed B.T., Wahbi A., Saedy A., Al Dabbagh T., Okaili R., Sadat M., Balkhy H. (2015). Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-Co V). Infection, 43: 495-501.

Assiri A., Mc Geer A., Perl T.M., Price C.S., Al Rabeeah A.A., Cummings D.A., Alabdullatif Z.N., Assad M., Almulhim A., Makhdoom H., Madani H., Alha - keem R., Al-Tawfiq J.A., Cotten M., Watson S.J., Kellam P., Zumla A.I., Mem- ish Z.A.; KSA MERS-Co V Investigation Team (2013). Hospital outbreak of Middle East respiratory syndrome coronavirus. N. Engl. J. Med., 369: 407-416.

Azhar E.I., El-Kafrawy S.A., Farraj S.A., Hassan A.M., Al-Saeed M.S., Hashem A.M., Madani T.A. (2014). Evidence for camel-to-human transmission of MERScoronavirus. N. Engl. J. Med., 370: 2499-2505.

Bermingham A., Chand M.A., Brown C.S., Aarons E., Tong C., Langrish C., Ho - schler K., Brown K., Galiano M., Myers R., Pebody R.G., Green H.K., Bod-dington N.L., Gopal R., Price N., Newsholme W., Drosten C., Fouchier R.A., Zambon M. (2012). Severe respiratory illness caused byanovel coronavirus, inapatient transferred to the United Kingdom from the Middle East, September 2012. Euro Surveill., 17: 20290.

Bosch B.J.,vander Zee R.,de Haan C.A., Rottier P.J. (2003). The coronavirus spike protein isaclass Ivirus fusion protein: structural and functional characterization of the fusion core complex. J. Virol., 77: 8801-8811.

Brand J.M.vanden , Smits S.L., Haagmans B.L. (2015). Pathogenesis of Middle East respiratory syndrome coronavirus. J. Pathol., 235: 175-184.

Briese T., Mishra N., Jain K., Zalmout I.S., Jabado O.J., Karesh W.B., Daszak P., Mohammed O.B., Alagaili A.N., Lipkin W.I. (2014). Middle East respiratory syndrome coronavirus quasispecies that include homologues of human isolates revealed through whole-genome analysis and virus cultured from dromedary camels in Saudi Arabia.m Bio, 5: 01146-1114.

Burkard C., Verheije M.H., Wicht O.,van Kasteren S.I.,van Kuppeveld F.J., Haagmans B.L., Pelkmans L., Rottier P.J., Bosch B.J.,de Haan C.A. (2014). Coronavirus cell entry occurs through the endo-/lysosomal pathway inaproteolysis-dependent manner. PLo S Pathog., 10: e1004502.

Cai Y., Yú S.Q., Postnikova E.N., Mazur S., Bernbaum J.G., Burk R., Zhang T., Ra - doshitzky S.R., Müller M.A., Jordan I., Bollinger L., Hensley L.E., Jahrling P.B., Kuhn J.H. (2014). D26/DPP4 cell-surface expression in bat cells correlates with bat cell susceptibility to Middle East respiratory syndrome coronavirus (MERS-Co V) infection and evolution of persistent infection. PLo S One, 9: e112060.

CDC - Centers for Disease Control and Prevention (2014). Middle East Respiratory Syndrome (MERS). http://www.cdc.gov/coronavirus/mers/CIDRAP - Center for Infectious Disease Research and Policy (2014). Gush of MERScases sparks speculation about causes. http://www.cidrap.umn.edu/news-perspective/2014/04/gush-mers-casessparks- speculation-about-causes Drexler J.F., Corman V.M., Wegner T., Tateno A.F., Zerbinati R.M., Gloza- Rausch F., Seebens A., Müller M.A., Drosten C. (2011). Amplification of emerging viruses inabat colony. Emerg. Infect. Dis., 17: 449-456.

ECDC - European Centre for Disease Prevention and Control. (2014) Epidemiological update: Middle East respiratory syndrome coronavirus (MERS-Co V), 30 April. http://ecdc.europa.eu/en/press/news/_layouts/forms/News_DispForm.aspx?List=8db7286c-fe2d-476c-9133-18ff4cb1b568&ID=994.

Fanoy E.B.,vander Sande M.A., Kraaij-Dirkzwager M., Dirksen K., Jonges M.,vander Hoek W., Koopmans M.P.,vander Werf D., Sonder G.,vander Weijden C.,vander Heuvel J., Gelinck L., Bouwhuis J.W.,van Gageldonk- Lafeber A.B. (2014). Travel-related MERS-Co Vcases: an assessment of exposures and risk factors inagroup of Dutch travellers returning from the Kingdom of Saudi Arabia, May 2014. Emerg. Themes Epidemiol., 11: 16.

Gardner L.M., Rey D., Heywood A.E., Toms R., Wood J., Waller T.S., Mac Intyre R.C. (2014). Ascenario-based evaluation of the Middle East respiratory syndrome coronavirus and the hajj. Risk Anal., 34: 1391-1400.

Gloza- Rausch F., Ipsen A., Seebens A., Göttsche M., Panning M., Drexler J.F., Petersen N., Annan A., Grywna K. et al. (2008). Detection and prevalence patterns of group Icoronaviruses in bats, northern Germany. Emerg. Infect. Dis., 14: 626-631.

Hemida M.G., Perera R.A., Wang P., Alhammadi M.A., Siu L.Y., Li M., Poon L.L., Saif L., Alnaeem A., Peiris M. (2013). Middle East respiratory syndrome (MERS) coronavirus seroprevalence in domestic livestock in Saudi Arabia, 2010 to 2013. Euro Surveill., 18: 20659.

Hemida M.G., Perera R.A., Al Jassim R.A., Kayali G., Siu L.Y., Wang P., Chu K.W., Perlman S., Ali M.A., Alnaeem A., Guan Y., Poon L.L., Saif L., Peiris M. (2014). Seroepidemiology of Middle East respiratory syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity. Euro Surveill., 19: 20828.

Hijawi B., Abdallat M., Sayaydeh A., Alqasrawi S., Haddadin A., Jaarour N., Alsheikh S., Alsanouri T. (2013). Novel coronavirus infections in Jordan, April 2012: epidemiological findings fromaretrospective investigation. East. Mediterr. Health J., 19, Suppl 1: S12-8.

Inoue Y., Tanaka N., Tanaka Y., Inoue S., Morita K., Zhuang M., Hattori T., Su - gamura K. (2007) Clathrin-dependent entry of severe acute respiratory syndrome coronavirus into target cells expressing ACE2 with the cytoplasmic tail deleted. J. Virol., 81: 8722-8729.

Ithete N.L., Stoffberg S., Corman V.M., Cottontail V.M., Richards L.R., Schoe- man M.C., Drosten C., Drexler J.F., Preiser W. (2013). Close relative of human Middle East respiratory syndrome coronavirus in bat, South Africa. Emerg. Infect. Dis., 19: 1697-1699.

Kindler E., Jónsdóttir H.R., Muth D., Hamming O.J., Hartmann R., Rodriguez R., Gefferse R., Fouchier R.A.M., Drosten C., Müller M.A., Dijkmana R., Thiela V. (2013). Efficient replication of the novel human betacoronavirus EMCon primary human epithelium highlights its zoonotic potential,m Bio, 4: e00611-12.

Memish Z.A., Alsahly A., Masri M.A., Heil G.L., Anderson B.D., Peiris M., Khan S.U., Gray G.C. (2012). Sparse evidence of MERS-Co Vinfection among animal workers living in Southern Saudi Arabia during 2012. Influenza Other Respir Viruses. 9: 64

Memish Z.A., Alsahly A., Masri M.A., Heil G.L., Anderson B.D., Peiris M., Khan S.U., Gray G.C. (2012). Sparse evidence of MERS-Co Vinfection among animal workers living in Southern Saudi Arabia during 2012. Influenza Other Respir Viruses, 9: 64-67.

Memish Z.A., Mishra N., Olival K.J., Fagbo S.F., Kapoor V., Epstein J.H., Al - Hakeem R., Durosinloun A., Al Asmari M., Islam A., Kapoor A., Briese T., Daszak P., Al Rabeeah A.A., Lipkin W.I. (2013). Middle East respiratory syndrome coronavirus in bats, Saudi Arabia. Emerg. Infect. Dis., 19: 1819-1823.

Memish Z.A., Al-Tawfiq J.A., Makhdoom H.Q., Al-Rabeeah A.A., Assiri A., Alha - keem R.F., Al Rabiah F.A., Al Hajjar S., Albarrak A., Flemban H., Balkhy H., Barry M., Alhassan S., Alsubaie S., Zumla A. (2014 a). Screening for Middle East respiratory syndrome coronavirus infection in hospital patients and their healthcare worker and family contacts:aprospective descriptive study. Clin. Microbiol. Infect., 20: 469-474.

Memish Z.A., Assiri A., Almasri M., Alhakeem R.F., Turkestani A., Al Rabeeah A.A., Al-Tawfiq J.A., Alzahrani A., Azhar E., Makhdoom H.Q., Hajomar W.H., Al - Shangiti A.M., Yezli S. (2014 b). Prevalence of MERS-Co Vnasal carriage and compliance with the Saudi health recommendations among pilgrims attending the 2013 hajj. J. Infect. Dis., 210: 1067-1072.

MEROPS - the Peptidase Database. Summary for peptidase S09.003: dipeptidyl-peptidase IV (eukaryote). http://merops.sanger.ac.uk/cgi-bin/pepsum?id=S09.003;type=P.

Müller M.A., Raj V.S., Muth D., Meyer B., Kallies S., Smits S.L., Wollny R., Beste- broer T.M., Specht S., Suliman T., Zimmermann K., Binger T., Eckerle I., Tschapka M., Zaki A.M., Osterhaus A.D.M., Fouchier R.A.M., Haagmans B.L., Drosten C. (2012). Human coronavirus EMCdoes not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines.m Bio, 3: e00515-12.

Müller M.A., Corman V.M., Jores J., Meyer B., Younan M., Liljander A., Bosch B., Lattwein E., Hilali M., Musa B.E., Bornstein S., Drosten C. (2014). MERS Coronavirus neutralizing antibodies in camels, Eastern Africa, 1983-1997. Emerg. Infect. Dis., 20: 2093-2095.

Nowotny N., Kolodziejek J.A. (2013). Middle East respiratory syndrome coronavirus (MERSCo V) in dromedary camels, Oman, 2013. Euro Surveill., 19: 20781.

Nowotny N., Kolodziejek J.A. (2014). Middle East respiratory syndrome coronavirus (MERSCo V) in dromedary camels: are dromedary camelsareservoir for MERS-Co V? Euro Surveill., 19: 20810.

Payne D.C., Iblan I., Alqasrawi S., Al Nsour M., Rha B., Tohme R.A., Abedi G.R., Farag N.H., Haddadin A., Al Sanhouri T., Jarour N., Swerdlow D.L., Jamie- son D.J., Pallansch M.A., Haynes L.M., Gerber S.I., Al Abdallat M.M.; Jordan MERS-Co V Investigation Team. (2014). Stillbirth during infection with Middle East respiratory syndrome coronavirus. J. Infect. Dis., 209: 1870-1872.

Qian Z., Dominguez S.R., Holmes K.V. (2013) Role of the spike glycoprotein of human Middle East respiratory syndrome coronavirus (MERS-Co V) in virus entry and syncytia formation. PLo S One, 8: e76469.

Raj V.S., Mou H., Smits S.L., Dekkers D.H., Müller M.A., Dijkman R., Muth D.,Demmers J.A., Zaki A., Fouchier R.A., Thiel V., Drosten C., Rottier P.J., Os - terhaus A.D., Bosch B.J., Haagmans B.L. (2013) Dipeptidyl peptidase 4 isafunctional receptor for the emerging human coronavirus-EMC. Nature, 495: 251-254.

Reusken C.B., Lina P.H., Pielaat A.,de Vries A., Dam- Deisz C., Adema J., Drex - ler J.F., Drosten C., Kooi E.A. (2010). Circulation of group 2 coronaviruses inabat species common to urban areas in Western Europe. Vector-Borne Zoonot., 10: 785-791.

Reusken C.B., Haagmans B.L., Müller M.A., Gutierrez C., Godeke G., Meyer B., Muth D., Raj V.S., Smits- De Vries L., Corman V.M., Drexler J.F., Smits S.L., El Tahir Y.E., De Sousa R.,van Beek J., Nowotny N.,van Maanen K., Hidalgo- - Hermoso E., Bosch B.J., Rottier P., Osterhaus A., Schmidt C.G., Drosten C., Koopmans M.P.G. (2013 a). Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels:acomparative serological study. Lancet Infect. Dis., 13: 859-866.

Reusken C.B., Ababneh M., Raj V.S., Meyer B., Eljarah A., Abutarbush S., Gode - ke G.J., Bestebroer T.M., Zutt I., Muller M.A., Bosch B.J., Rottier P.J., Oster- haus A.D., Drosten C., Haagmans B.L., Koopmans M.P. (2013 b). Middle East respiratory syndrome coronavirus (MERS-Co V) serology in major livestock species in an affected region in Jordan, June to September 2013. Euro Surveill., 18: 20662.

Reusken C.B., Farag E.A., Jonges M., Godeke G.J., El-Sayed A.M., Pas S.D., Raj V.S., Mohran K.A., Moussa H.A., Ghobashy H., Alhajri F., Ibrahim A.K., Bosch B.J., Pasha S.K., Al-Romaihi H.E., Al-Thani M., Al-Marri S.A., Al Hajri M.M., Haagmans B.L., Koopmans M.P. (2014). Middle East respiratory syndrome coronavirus (MERS-Co V) RNAand neutralising antibodies in milk collected according to local customs from dromedary camels, Qatar, April 2014. Euro Surveill., 19: 20829.

Wang H., Yang P., Liu K., Guo F., Zhang Y., Zhang G., Jiang C. (2008). SARScoronavirus entry into host cells throughanovel clathrin- and caveole-independent endocytic pathway. Cell Res., 18: 290-301.

World Health Organization (2004). Summary of probable SARScases with onset of illness from 1 November 2002 to 31 July 2003. http://www.who.int/csr/sars/country/table2004_04_21/en/.

World Health Organization (2014 a). Middle East respiratory syndrome coronavirus (MERS-Co V) - Saudi Arabia. http://www.who.int/csr/don/03-november-2014-mers/en/.

World Health Organization (2014 b). Middle East respiratory syndrome coronavirus (MERS-Co V) - update, 13 June 2014. http://www.who.int/csr/don/2014_06_13_mers/en/.

World Health Organization (2014 c). Middle East respiratory syndrome coronavirus (MERS-Co V) - update, 3 January 2014. http://www.who.int/csr/don/2014_01_03/en/.

World Health Organization (2014 d). Middle East respiratory syndrome coronavirus (MERS-Co V) - update, 7 May 2014. http://www.who.int/csr/don/2014_01_03/en/.

World Health Organization (2015). Middle East respiratory syndrome coronavirus (MERS-Co V) - Saudi Arabia. 2015, 15 January. http://www.who.int/csr/don/15-january-2015-mers/en/.

Yang Y., Du L., Liu C., Wang L., Mab C., Tang J., Baricc R.S., Jiang S., Lia F. (2014). Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERScoronavirus. Proc. Natl. Acad. Sci. USA, 111: 12516-12521.

Zaki A.M.,van Boheemen S., Bestebroer T.M., Osterhaus A.D.M., Fouchier R.A.M. (2012). Isolation ofanovel coronavirus fromaman with pneumonia in Saudi Arabia. N. Engl. J. Med., 367: 1814-1820.

Annals of Animal Science

The Journal of National Research Institute of Animal Production

Journal Information


IMPACT FACTOR 2017: 1.018
5-year IMPACT FACTOR: 0.959



CiteScore 2017: 1.01

SCImago Journal Rank (SJR) 2017: 0.413
Source Normalized Impact per Paper (SNIP) 2017: 0.822

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 195 195 19
PDF Downloads 78 78 7